Press Releases

Featured Press Releases

New BIO Working Groups Give Growing Ag &…

Updated regulatory working groups announced today by the Biotechnology Innovation Organization (BIO) reflect the rapidly increasing diversity and impact of BIO’s Agriculture & Environment membership and ensure that all member companies’…

Learn more

ORPHAN Cures Act a "welcome and bipartisan fix"…

Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) today introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). BIO President and CEO, Rachel King, made the following remarks: "This legislation is a welcome…

Learn more

BIO Honors Biotech Leaders for Breakthroughs in…

The Biotechnology Innovation Organization has honored two biotechnology leaders who are driving cutting-edge breakthroughs in agricultural, environmental and industrial biotechnology. Dr. Pam Marrone, Co-founder and Executive Chair of Invasive…

Learn more

New BIO Working Groups Give Growing Ag & Environment Biotech Sector a Public Policy Voice

September 27, 2023

ORPHAN Cures Act a "welcome and bipartisan fix" to the IRA's negative impact on drug development

September 18, 2023

BIO Honors Biotech Leaders for Breakthroughs in Ag & Environment Biotech

September 12, 2023

BIO Applauds FTC Settlement Decision

September 1, 2023

Yesterday the Federal Trade Commission (FTC) announced the decision to settle its Amgen-Horizon merger challenge. The settlement will give the Commission the relief it needs to protect competition, while allowing rare disease patients to enjoy the…

BIO Podcast 2023 Fall Season Launch

August 30, 2023

New Season of I am BIO Podcast Covers Birds, Bees, and Bugs Fall 2023 season explores biotech solutions for wildlife conservation, bee health, drug-resistant bugs, and more Washington – (Aug. 30, 2023) – Save the date―the Biotechnology Innovation…

BIO Statement on CMS Announcement of First 10 Drugs Subject to Price Controls Under IRA

August 29, 2023

The Biden Administration today unveiled the first 10 prescription drugs that will be subject to price controls under the Inflation Reduction Act (IRA). Rachel King, BIO interim President and CEO, made the following statement: The Medicare price…

BIO FILES AMICUS BRIEF CHALLENGING FTC’S OVERREACH ON MERGER ENFORCEMENT THAT THREATENS DRUG DEVELOPMENT INNOVATION

August 24, 2023

BIO released the following statement from John Delacourt, BIO’s Deputy General Counsel, on BIO’s amicus brief opposing the Federal Trade Commission (FTC) lawsuit to block the acquisition of Horizon by Amgen: “The FTC’s current overreach in…

Dispute Panel 'Important Next Step' to Return to Science-Based Trade with Mexico

August 17, 2023

The following statement may be attributed to Nancy Travis, vice president of international affairs, BIO. “The Biotechnology Innovation Organization supports today’s action by the Office of the U.S. Trade Representative to request formation of a…

How BIO Used New Social Sharing Technology to Drive High Engagement Leading Up to the 2023 BIO International Convention

August 9, 2023

Using organic social sharing techniques and tools, BIO’s social media team was able to drive record levels of engagement for their premier event. For social media managers, successfully reaching an organization’s member companies, partners, and…

Majority of U.S. Voters Support Streamlined Biotech Regulations

August 3, 2023

New BIO/Morning Consult survey shows strong support for biotech innovation and its role in addressing critical global challenges. The majority of U.S. voters (62%) hold a favorable opinion of biotechnology and view its benefits as important,…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.